600276.SS
600276.SS
CNE0000014W7
JIANGSU HENGRUI PHARMACEUTICALS
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 31.629.416.194 27.984.605.342
13.0%
Cost of Revenue 4.362.655.815 3.848.177.392
13.4%
Gross Profit 27.266.760.378 24.136.427.950
13.0%
18.670.348.627 17.333.295.381
7.7%
Operating Income 8.596.411.752 6.803.132.569
26.4%
Pretax Income 8.707.625.538 7.169.689.996
21.5%
Net Income Common Stockholders 7.711.054.812 6.336.527.015
21.7%
-- --
--
-- --
--
ende